8-K/A filing — Processa Pharmaceuticals, Inc. (PCSA)
Filed: 2026-10-05 AccNo: 0001140361-26-038535 Size: 3 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filings · News reference
Processa Pharmaceuticals Files Prospectus For Offering 306.574M Common Shares On Behalf Of Selling Shareholders
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Processa Pharmaceuticals, Inc. (PCSA)
Filed: 2026-08-04 AccNo: 0001493152-26-036032 Size: 226 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Crude Oil Surges 7%; General Dynamics Posts Upbeat Earnings
Dow Jones falls 800+ pts; energy shares up 2.6%; General Dynamics beats earnings estimates; Verra Mobility reaches agreement with Avis.